Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/22/2003EP1353684A2 Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia
10/22/2003EP1353679A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/22/2003EP1353678A2 Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
10/22/2003EP1353677A2 Method of treatment of type i diabetes with vitamin d compounds
10/22/2003EP1353676A1 Method for treating fibrotic diseases or other indications
10/22/2003EP1353675A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
10/22/2003EP1353674A1 Method for treating glaucoma ivb
10/22/2003EP1353673A1 Camptothecin derivatives
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353671A1 Neurotrophic tacrolimus analogs
10/22/2003EP1353670A2 Use of chromanes
10/22/2003EP1353669A1 Method for treating glaucoma ib
10/22/2003EP1353668A1 Methods of administering epothilone analogs for the treatment of cancer
10/22/2003EP1353667A1 Parenteral formulations containing epothilone analogs
10/22/2003EP1353665A1 Treatment of depression
10/22/2003EP1353664A2 Heterocycle derivatives and methods of use for treating anthrax infection
10/22/2003EP1353663A1 Fenofibrate tablets
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353661A2 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
10/22/2003EP1353660A2 Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
10/22/2003EP1353659A1 Use of neurotoxic substances in producing a medicament for treating joint pains
10/22/2003EP1353658A1 Regulation of organic nitrate tolerance
10/22/2003EP1353656A2 Method for treating stress or tension
10/22/2003EP1353655A2 Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
10/22/2003EP1353652A2 Pharmaceutical tablet comprising paroxetine mesylate
10/22/2003EP1353651A2 Extended release pharmaceutical compositions containing beta-lactam antibiotics
10/22/2003EP1353650A2 Process for preparing non-hygroscopic sodium valproate composition
10/22/2003EP1353648A2 Microparticles of biodegradable polymer encapsulating a biologically active substance
10/22/2003EP1353647A2 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
10/22/2003EP1353645A1 Method for the production and use of a cream containing vitamin-a.
10/22/2003EP1353644A1 Use of an isothiocyanate, a thiocyanate or a mixture thereof as depigmenting agent
10/22/2003EP1353624A2 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
10/22/2003EP1353569A2 Preparation for improved dietary utilisation
10/22/2003EP1353556A2 Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
10/22/2003EP1281715B1 Process for the preparation of ribavirin
10/22/2003EP1255538B1 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for the manufacture of a medicament for treating and/or preventing cancers
10/22/2003EP1196135B1 Compositions comprising organosiloxane resins for delivering oral care substances
10/22/2003EP1194441B1 A2a receptor agonists
10/22/2003EP1192122B1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
10/22/2003EP1183236B1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
10/22/2003EP1178966B1 Quinoline derivatives as inhibitors of mek enzymes
10/22/2003EP1177167B1 High purity (1r, 2s, 4r)-(-)-2-[(2'-(n,n-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them.
10/22/2003EP1164996B1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones
10/22/2003EP1150961B1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
10/22/2003EP1150661B1 Topical sprays comprising a film forming composition
10/22/2003EP1149076B1 O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
10/22/2003EP1144423B1 Bis-terpyridine-platinum(ii) complexes
10/22/2003EP1144386B1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/22/2003EP1140803B1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/22/2003EP1140745B1 Colchinol derivatives as vascular damaging agents
10/22/2003EP1140105B1 Controlled release galantamine composition
10/22/2003EP1140031B1 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
10/22/2003EP1131073B1 Use of staurosporine derivatives for treating ocular neovascular diseases
10/22/2003EP1089993B1 5-ht1f agonists
10/22/2003EP1084122B1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
10/22/2003EP1083168B1 Prostaglandin derivative
10/22/2003EP1071404B1 Softgel-compatible composition containing retinol
10/22/2003EP1056754B1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
10/22/2003EP1056744B1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
10/22/2003EP1056701B1 E-2- 4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof
10/22/2003EP1056460B1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
10/22/2003EP1053244B1 Glycosidation of 4,5-epoxymorphinan-6-ols
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003EP1043977B1 Oral pharmaceutical pulsed release dosage form
10/22/2003EP1041984B1 Pharmaceutical composition for oral administration
10/22/2003EP1032566B9 Method for the preparation of citalopram
10/22/2003EP1007523B1 Indole and 2,3-dihydroindole derivatives, their preparation and use
10/22/2003EP1003749B1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h/2,3/BENZODIAZEPINE DERIVATES, AS AMPA/KAINATERECEPTOR INHIBITORS
10/22/2003EP0986572B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
10/22/2003EP0980368B1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
10/22/2003EP0929293B1 Liposomes containing a cisplatin compound
10/22/2003EP0927184B1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use
10/22/2003EP0910253B1 Peri-operative drink
10/22/2003EP0908182B1 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
10/22/2003EP0896522B1 Methods of regulating skin appearance with vitamin b 3 compound
10/22/2003EP0892802B1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors
10/22/2003EP0881218B1 Preventives/remedies for complications of diabetes
10/22/2003EP0863901B1 Carbapenem antibiotic, composition and method of preparation
10/22/2003EP0862424B1 Pharmaceutical compositions comprising flurbiprofen
10/22/2003EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis
10/22/2003EP0847446B1 PRODUCTION OF BETA-GLUCAN-MANNAN PREPARATIONS BY AUTOLYSIS OF CELLS UNDER CERTAIN pH, TEMPERATURE AND TIME CONDITIONS
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003EP0699069B9 Endothelin receptor antagonists
10/22/2003EP0658209B1 Endothelial lineage specific transcriptional regulatory element from tek
10/22/2003EP0651654B1 Use of lysozyme dimer for the manufacture of a medicament for modulating natural defensive mechanisms
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451041A Compound composition and method for the treatment of inflammatory and inflammatory-related disorders
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1451011A 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof
10/22/2003CN1451010A Benzosulfones with calcium antagonist activity
10/22/2003CN1451009A Glucocortiocoid-selective antinflammatory agents
10/22/2003CN1451008A Pyranoindoles for treating alaucoma
10/22/2003CN1451007A Adenosine A2A receptor antagonists
10/22/2003CN1451006A I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives
10/22/2003CN1451005A 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1451002A Indole derivatives for treating central nervous system disease
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
1 ... 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 5320 5321 5322 5323 ... 7860